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Abstract 
Bacteria that have acquired resistance to antibiotics represent one of the largest threats to 
human health and modern health care. The genes encoding resistance are frequently 
spread via the transfer of plasmids, which are circular double stranded DNA molecules 
separate from the chromosomal DNA of the bacteria. The increasing prevalence of 
resistant bacteria, in combination with the absence of new major discoveries of 
antimicrobial drugs, means that health care could soon be entering a “post-antibiotic era”. 
Besides developing new drugs, methods capable of rapidly detecting bacteria that have 
acquired resistance to antibiotics are of paramount importance for clinical point of care 
applications. 
In this Thesis, the development of an assay for rapid plasmid characterization is 
described. The method is based on optical DNA mapping using competitive binding of 
the fluorophore YOYO-1 and the sequence-specific, non-fluorescent, molecule netropsin, 
to DNA. The fluorescently labeled DNA is stretched in nanofluidic channels and imaged 
using fluorescence microscopy, enabling coarse-grained sequence information to be read 
from the intact plasmid at the single plasmid level. Additionally, an approach for gene 
detection on individual plasmids is described, combining the CRISPR/Cas9 system with 
optical DNA mapping. 
The results demonstrate how the assay can be used to obtain the number of different 
plasmids in a sample, the size of each plasmid, an optical barcode for tracing and 
identification, as well as information about which plasmid that carries a specific 
(resistance) gene. Overall, the assay shows great potential as a first step of plasmid 
characterization in point of care diagnostics. 
Keywords: plasmids, nanofluidics, antibiotic resistance, DNA, single-molecule, optical 
mapping, competitive binding, CRISPR/Cas9, fluorescence microscopy.  
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1 Introduction 
 
“A post-antibiotic era—in which common infections and minor injuries can kill—far from being an 
apocalyptic fantasy, is instead a very real possibility for the 21st century.” 
– Dr. Keiji Fukuda, World Health Organization, 2014 
Almost a century has passed since the ground breaking discovery of penicillin by Fleming 
(1) in 1928, that paved the way for the first clinical use of antibiotics just over a decade 
later (2). The discovery of antibiotics is regarded as one of the largest break troughs in 
medicine and antibiotics are today one of the main foundations of modern health care. 
However, significant overuse of antibiotics, in combination with the lack of new major 
discoveries, has led to a situation where bacteria have started to acquire resistance to more 
or less all effective antibiotics, compromising our ability to treat even common bacterial 
infections (3, 4). 
In order to avoid a post-antibiotic era, there is a need for drastically reducing the use of 
antibiotics, as well as finding new alternative treatments, either in the form of new 
antibiotics, or by discovering novel ways to target bacterial infections. Additionally, there 
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is an urgent need for rapid point-of-care (POC) diagnostics in order to replace the 
inherently slow (>36 hours) assays that are standard today, based on cultivating the 
bacteria in the presence of different antibiotics (3, 5). With quick and robust tools for 
diagnostics, adequate treatment could be administered faster and existing antibiotics 
could be used more efficiently, allowing to spare the “last resort” antibiotics. 
One main reason for the rapid spread of antibiotic resistance is horizontal gene transfer, 
where genes located on mobile genetic elements, such as plasmids, allow resistance to be 
spread between different bacterial strains and species (6-8). Existing tools for 
characterizing plasmids allow to measure plasmid size (9), group plasmids based on 
specific genes (10), and retrieve the entire deoxyribonucleic (DNA) sequence (11). 
However, at present, available methods that provide enough information for reliable 
diagnostics suffer from either being slow or complex and expensive, hampering their use 
in clinics (5, 12, 13). 
The aim of this Thesis is to describe the development of a novel assay for rapid plasmid 
characterization based on optical DNA mapping. Pioneered by Schwartz et al. (14) almost 
25 years ago, optical DNA mapping has proven to be a versatile tool for extracting long 
range sequence information of DNA at the kilo base pair (kbp) level (15, 16). For the assay 
described in this Thesis, fluorescently labeled DNA is stretched in nanofluidic channels, 
and imaged using fluorescence microscopy. This approach enables coarse-grained 
sequence information to be read from intact plasmids at the single plasmid level. Hence, 
the assay introduces the possibility to study structural variations without averaging, as 
well as to avoid the time consuming step of bacterial cultivation before subsequent 
analysis. The latter is a key stepping stone for rapid POC diagnostics of antibiotic 
resistance. 
This general introduction is followed by two chapters in which theoretical background is 
provided to some of the main topics related to the presented research (Chapter 2), along 
with a description of the key methodologies used (Chapter 3). The original work in this 
Thesis, which is summarized and discussed in Chapter 4, is based on the three appended 
papers, from here on referred to as Paper I-III. 
Paper I demonstrates how optical DNA mapping can be used to study intact plasmid 
DNA molecules. An assay was developed to identify and characterize plasmids with 
genes encoding antibiotic resistance, by comparing to a database of all available 
sequenced plasmids. Paper II applies and extends the assay presented in Paper I, 
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enabling plasmids extracted directly from clinical isolates originating from a nosocomial 
outbreak at a neonatal ward at Sahlgrenska University Hospital to be studied. By 
simultaneously extracting information about the size, as well as the underlying sequence 
of the investigated plasmids, it was possible to trace plasmids between different bacterial 
strains, species and even patients. Paper III adds to the work in Paper I and Paper II by 
introducing a CRISPR/Cas9 based approach for gene targeting, allowing resistance genes 
to be directly detected from optical DNA maps of single plasmids. 
Finally, Chapter 5 provides some concluding remarks, as well as a discussion about future 
directions of the research. 
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2 Background 
 
In this chapter, background information is provided on key topics, relevant for the work 
presented in the Thesis. First, the DNA molecule is described, with focus on structure and 
molecular interactions. Moreover, the basics of bacteria, and especially their plasmids, is 
presented, in combination with available techniques for plasmid characterization. 
Information is also provided regarding antibiotic resistance, including existing 
knowledge about bacterial defense and transfer mechanisms. Finally, an introduction to 
the field of optical DNA mapping is given. 
2.1 DNA 
During the 20th century, the understanding of deoxyribonucleic acid, DNA, and its role in 
biological systems started to grow. Avery and co-workers showed in 1944 that DNA, and 
not proteins as previously supposed, was responsible for inheritance (17). Still, the 
mechanism of genetic heredity remained a mystery until Watson and Crick published the 
structure of double stranded DNA (dsDNA) (Figure 1) in 1953 (18), followed by a 
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suggestion on how genetic material could be replicated and transferred to the next 
generation (19). 
 
 
Figure 1: Molecular structure of DNA. Left: Helical arrangement of the two strands, linked via 
hydrogen bonding between the DNA bases. Right: Molecular structure of the four different DNA 
bases, thymine (green), adenine (red), guanine (yellow) and cytosine (blue), with hydrogen bonds 
displayed as dashed lines. The DNA backbone, consisting of a sugar and a phosphate group, is shown 
in gray. 
 
2.1.1 Structure and Biological Function 
The structure of DNA can be described as pairs of different nucleotides. A nucleotide 
consists of three distinct units, a phosphate, a deoxyribose sugar and a nitrogen base. In 
contrast to the phosphate and deoxyribose sugar, which always are the same, there are 
four different nitrogen bases that make up the DNA structure, thymine (T), adenine (A), 
cytosine (C) and guanine (G), where T and C belong to the family of pyrimidines and A 
and G are purines. Hence, there are four possible nucleotide versions, each containing one 
of the four different nitrogen bases. 
The nucleotides are connected by phosphodiester bonds between the phosphate and 
sugars, leading to the formation of single stranded DNA (ssDNA). Each nucleotide is 
associated with its neighbor from the 5’ carbon on the sugar of the first nucleotide, to the 
3’ carbon on the subsequent nucleotide. Hence, ssDNA will have an inherent direction. 
The two DNA strands are in turn connected by hydrogen bonding between the nitrogen 
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bases to create the double stranded helix, where A base pairs with T by forming two 
hydrogen bonds, and G with C, forming three bonds (Figure 1). Three different natural 
forms of DNA are known, commonly denoted A, B and Z. The B form, which is by far the 
most abundant in nature, has an overall negative charge under physiological conditions 
and displays a right-handed helix structure, with a twist angle of 36 degrees, and a rise of 
0.34 nm, per base pair (bp) (20). 
Following the understanding of the DNA structure, the central dogma of molecular 
biology was revealed (Figure 2), explaining the relationship between DNA, ribonucleic 
acid (RNA) and proteins (21, 22). Proteins are long chains built up by twenty different 
amino acids, linked via peptide bonds. The order of these amino acids in each protein is 
encoded by a triplet of DNA bases, information that is transferred via RNA molecules. 
 
 
Figure 2: Schematic illustration of the central dogma of molecular biology. The genetic information 
stored in DNA, based on the order of the nucleotides, can be replicated, as well as used as a template 
for RNA generation (transcription). The genetic information, now stored in the form of RNA, is 
subsequently used to enable protein synthesis via the process of translation. 
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2.1.2 Confined DNA 
When studying the behavior of DNA at larger length scales, it is not enough to consider 
only the basic chemistry of the nucleotides. Instead, the DNA can be modeled as a large 
polymer, built up by many monomeric subunits, characterized by parameters such as 
size, shape and molar mass. The size and shape of the DNA will depend on the degree of 
confinement, as well as the surrounding solvent, while the molar mass is determined by 
the number of monomers. 
In order to describe the behavior of DNA, both free in solution and when confined, some 
basic parameters need to be introduced. The contour length () of DNA is defined as the 
end to end distance of the DNA when fully stretched, and calculated by multiplying the 
number of monomers, base pairs, with their separation distance. The persistence length 
() of DNA is defined as the length of the unit over which the DNA cannot be bent, and 
varies with the ionic strength, with an approximate value of 50 nm under physiological 
conditions (23, 24). 
A DNA molecule free in solution will coil in order to minimize its free energy. The size of 
the coiled DNA can be described by the radius of gyration (), which is a measure of the 
root mean square distance of the segments to the center of the coil. Additionally, a 
parameter describing the dimensions of the confining environment is needed. The work 
in this Thesis is based on confining DNA inside nanochannels, in which the length of the 
channels are assumed to be infinitely long, while the width and height of the channels are 
restricted. The dimensions are generally expressed as the average cross section area () 
of the channel width () and height (), and calculated according to Equation (1) 
 = 	 ∙  (1) 
The degree of extension will depend on the persistence length (), channel dimensions 
(), as well as the radius of gyration (), of the DNA molecule (Figure 3). If the 
dimensions of the channels are larger than the radius of gyration ( < ), the DNA will 
act as when free in solution. If the channel dimensions are smaller than the radius of 
gyration, but still much larger than the persistence length ( ≪  < ), the DNA will be 
weakly confined and can be modeled as a series of non-interacting blobs with diameters 
similar to the cross section area, as explained by the theory of de Gennes (25). 
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Figure 3: Illustration of a DNA molecule under different degrees of confinement, where  is the 
radius of gyration and  is the persistence length of the DNA molecule, while  is the average cross 
section of the confining environment.  
 
However, if the channels have dimensions smaller than the persistence length ( < ), 
the DNA molecule will behave according to the theory developed by Odijk (26, 27). Here 
the DNA cannot coil up anymore and movement is restricted to only small undulations 
(Figure 3). For nanofluidic experiments involving DNA molecules, as for the work in this 
Thesis, the channel dimensions are similar to the persistence length ( ≤ ), resulting in 
that the experiments are conducted in a transition regime in-between the ones described 
by de Gennes and Odijk, commonly referred to as the extended de Gennes regime (28-
32). Notably, the degree of extension in the regimes described by both de Gennes and 
Odijk is directly proportional to the contour length of the DNA. Hence, sequence specific 
information positioned X% into the sequence can be observed X% into the nanoconfined 
DNA molecule. 
Finally, since the properties of DNA are sensitive to the concentration of ions, the degree 
of extension will depend on the ionic strength of the solution. For example, a lower 
concentration of ions in the solution will provide less shielding for the DNA from its own 
negatively charged backbone, increasing the stiffness, and thus increase the degree of 
extension. 
2.1.3 DNA Binding Molecules 
Due to the versatile chemical and structural properties of DNA, it provides other 
molecules a variety of possibilities to interact. Figure 4 shows four main ways a molecule, 
referred to as a ligand, can bind to DNA: external biding, binding to the minor or major 
groove of the DNA helix, and intercalation between the DNA base pairs. External binding 
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is facilitated by electrostatic interactions between a positively charged ligand and the 
negatively charged DNA backbone. Groove binders, on the other hand, rely on forming 
hydrogen bonds with the exposed bases in either the minor, or major groove. The minor 
groove allows for smaller, often curved, molecules, to bind along the twisted DNA helix. 
In contrast, larger molecules, such as proteins, are instead more frequently found to bind 
in the major grove, in which their larger structural motives can be harbored. Lastly, a 
ligand can insert one or several parts of its structure in the hydrophobic space created 
between the stacked DNA base pairs, a process referred to as intercalation. 
 
 
Figure 4: Schematic illustration of the four different binding modes, major (yellow) and minor (red) 
groove binding, external binding (blue) and intercalation (green), to DNA. 
 
For the work presented in this thesis, two DNA binding molecules, the bis-intercalating 
cyanine dye YOYO-1 (YOYO), as well as the AT-selective grove binder netropsin, have 
been extensively used (Figure 5). When studying DNA with fluorescence microscopy 
(Section 3.1.2), the inherently non-fluorescent DNA needs to be stained with a dye in 
order to enable visualization. For this purpose, cyanine dyes, such as YOYO, display 
favorable photophysical properties including high binding constants, high emission 
quantum yields and low background fluorescence. Details on emission of light, including 
fluorescence, can be found in Section 3.1.1. 
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Figure 5: Molecular structure and schematic representation of DNA binding molecules YOYO (left) 
and netropsin (right). 
 
YOYO binds to DNA by inserting its two aromatic ring structures in-between the base 
pairs, a process referred to as bis-intercalation (33, 34). When free in solution, YOYO is 
practically non-fluorescent, but once bound to DNA the rotation around the methane 
bridge is sterically hindered, increasing the emission more than a thousand-fold (33), 
making YOYO ideal for single molecule experiments. The maximum amount of YOYO 
bound to DNA, restricted by the nature of the binding mode, is approximately one YOYO 
molecule every four base pairs. External binding to the negatively charged DNA 
backbone is still possible, however at much lower binding affinities (34, 35). The binding 
of YOYO will also affect the structural properties of DNA. When inserting the two 
aromatic moieties between the DNA base pairs, YOYO will increase the effective contour 
length by 0.51 nm, as well as alter the helical twist, unwinding the DNA helix by 
approximately 24 degrees (36). Also, the positive charge (+4) of YOYO will reduce the 
overall negative charge of DNA. 
Netropsin is a non-fluorescent, natural antibiotic, which binds selectively to AT base pairs 
displayed in the minor grove of the DNA helix. While the molecular structure of netropsin 
(Figure 5) allows it to form hydrogen bonds with adenine and thymine, giving rise to a 
strong and site specific binding, the amino group present in guanine will sterically hinder 
netropsin from forming hydrogen bonds to GC base pairs (37, 38). Hence, the strength of 
binding between netropsin and DNA will depend on the 5bp site on which netropsin 
binds, with 5’-AAAAA-3’ allowing the strongest binding (39-41). 
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2.1.4 Enzymes for DNA Modification 
As previously mentioned, proteins are long chains of amino acids linked via peptide 
bonds. Proteins are often referred to as the machinery of the cell, capable of performing a 
variety of functions. Different groups of proteins include transporter proteins, receptor 
proteins, structural proteins and enzymes. The latter function by accelerating chemical 
reactions, regulating a myriad of processes in a highly selective matter within a living cell. 
For instance, enzymes are essential in the process of replication, repair and modification 
of DNA. 
One example of an enzyme involved in DNA modification is the Clustered Regularly 
Interspaced Short Palindromic Repeats (CRISPR) - associated protein-9 nuclease (Cas9) 
(42, 43), which has recently been developed into a gene editing tool capable of catalyzing 
highly sequence specific double stranded breaks, via the cleavage of the phosphodiester 
bonds in the DNA backbone (44, 45). The enzyme is involved in the adaptive immune 
system of bacteria and archaea (42, 46) and has found numerous scientific applications, 
including gene editing, targeting and regulation (47). 
In order for the Cas9 enzyme to find the specific DNA sequence at which it will produce 
a double stranded break, it utilizes a RNA molecule displaying a 20 bp complementary 
sequence to the site of interest (Figure 6). This RNA molecule is called guide RNA 
(gRNA), and can be further dived in to two parts, termed tracrRNA and crRNA. The 
tracrRNA is responsible for the association to the Cas9 enzyme, while the crRNA provides 
the complementary 20 bp sequence to the targeted site on the DNA molecule. Hence, the 
sequence of the tracrRNA will stay the same, while the crRNA sequence can be selected 
depending on the site of interest on the DNA molecule. The only constraint when 
selecting the crRNA sequence is that it has to be followed by a three base sequence (NGG), 
termed protospacer adjacent motif (PAM), allowing nearly any existing gene to be 
targeted with high precision. 
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Figure 6: Schematics of Cas9 binding and subsequent DNA cleavage aided by associated RNA 
molecules crRNA and tracrRNA. The double strand cleavage will take place approximately three 
nucleotides upstream of the protospacer adjacent motif (PAM) sequence. 
 
Forms of Cas9 that only selectively bind to DNA without producing a double strand break 
(48), as well as those only capable of producing a single strand break, have also been 
engineered. The first has been used in order to directly visualize sequence specific sites 
(49, 50), and the latter to induce double stranded breaks with higher precision (44, 51), or 
to mark the site of the single strand break by incorporating a fluorescent dye (52). Other 
enzymes capable of altering DNA, but with shorter recognition sites, are also readily 
available and have found several applications, for instance within the field of optical DNA 
mapping, further discussed in Section 2.4. 
2.2 Bacteria and Their Plasmids 
Bacteria are single cell organisms belonging to the family of prokaryotes, differing from 
human cells, eukaryotes, by not harboring membrane enclosed organelles. Only a few 
microns large, bacteria were one of the first life forms present on earth and can be found 
in a variety of different shapes and sizes (53). Bacteria reproduce by a process known as 
binary fission, where one mother cell divides to form two identical daughter cells. 
Figure 7 depicts the main components of a bacterial cell. The cell wall provides structural 
strength and functions as a barrier that separates the bacterium from its surroundings. On 
the cell wall surface of some types of bacteria, there are small finger like extensions, 
known as pili, aiding in the exchange of genetic material between bacterial cells. The main 
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intracellular component, present in the cytoplasm of the bacteria, is the nucleoid, which 
besides small amounts of RNA and protein, mainly consists of chromosomal DNA. The 
cytoplasm also contains ribosomes for protein synthesis. Apart for the chromosomal 
DNA, responsible for maintaining essential cell functions, genetic information within 
bacteria can also be stored in plasmids. 
 
 
Figure 7: Left: Simplified illustration of a bacterium and its major components. Cell wall and 
flagellum (green), pili (blue), nucleoid (red), ribosomes (yellow) and plasmids (gray). Right: 
Schematic illustration of a plasmid marked with a region encoding replication (green), including 
origin of replication (yellow), and a region encoding antibiotic resistance (blue). 
 
Termed by Lederberg in 1952 (54), plasmids are double stranded, circular DNA 
molecules, separate from the chromosome, capable of replicating autonomously. Figure 
7 shows a schematic representation of a plasmid, including the origin of replication (ORI). 
The ORI, as indicated by the name, is the DNA sequence at which the replication of the 
plasmid starts. The minimal portion of the plasmid required for replication, the replicon, 
includes, beside the ORI, genes encoding proteins that assist in the replication process, as 
well as in plasmid maintenance. Different plasmids that share one or more elements of 
the replication mechanism cannot co-exist in the same cell, a phenomenon referred to as 
plasmid incompatibility (55). The copy number, i.e., the number of copies of a specific 
plasmid within the cell, can range between a single to over a hundred (56), and the size 
spans between 1 kbp to over 1 mega base pair (Mbp). 
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Even though plasmids are not required for a bacterium to regulate and maintain its basic 
functions, they play a key role when a bacterium needs to adapt to a new environment, 
for instance when exposed to antibiotics (57). Plasmids are capable of horizontal gene 
transfer (details in Section 2.3.2), allowing them to spread between different bacterial 
strains and species. Moreover, plasmids are very dynamic, capable of amplifying 
beneficial genes, as well as deleting those that no longer have any desired function (58). 
Similarly, many plasmids possess the ability to insert external DNA into its sequence, 
hence acquiring new genetic material (8). 
2.2.1 Current Methods for Plasmid Analysis 
The dynamic nature of plasmids has made them central in the rapid spread of antibiotic 
resistance (Section 2.3), but at the same time hard to study. However, there are tools 
available for characterizing plasmids, allowing information about size, type and sequence 
to be extracted. As a standard method for plasmid sizing, S1-coupled pulsed field gel 
electrophoresis (S1/PFGE) is used (9). After linearization via S1 nuclease (59), the plasmids 
are separated by applying an alternating (pulsed) electric field over an agarose gel, in 
which the plasmids migrate due to their negatively charged DNA backbone. Since smaller 
DNA molecules will travel faster through the pores of the gel, a non-linear separation 
based on size is obtained. Staining the DNA with a fluorescent dye enables visualization 
of the dominating plasmid bands on the gel. By adding DNA molecules of pre-known 
size to the same experiment as reference, the size of the plasmids can be determined. 
There are several methods for plasmid characterization that are based on the polymerase 
chain reaction (PCR) (60). The general idea is to find out if a particular sequence, defined 
in advance, is present on the DNA molecule of interest, in this case a plasmid. The PCR 
reaction can be divided into three main steps: denaturation, annealing and elongation. 
After heating the DNA, causing the DNA to denature into two separate strands, pre-
designed, short base pair sequences, complementary to the sequence of interest (primers) 
are added to the reaction. Once the primers have annealed with the single stranded DNA, 
the DNA is elongated by further addition of nucleotides and a DNA polymerase. 
Provided that the sequence is present, there is a two-fold increase of the targeted DNA 
sequence each time the cycle is repeated. The targeted sequence is detected by performing 
gel electrophoresis on the PCR product, or by using quantitative real time PCR (qPCR), 
utilizing fluorescence for instant read out during the experiment (61). 
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Plasmid based replicon typing (PBRT) utilizes PCR in order to group plasmids based on 
their replication mechanism (10, 62). In the otherwise very dynamic plasmids, the replicon 
is a highly conserved region, making it an ideal target for plasmid classification. As 
mentioned in Section 2.2, two plasmids that share one or more parts of their replication 
mechanism cannot propagate in the same bacterial cell, they are said to be incompatible. 
Designing primers complementary to different regions found in the replicon thus allows 
plasmids to be divided into different groups based on their incompatibility, referred to as 
Inc groups. It should be noted that one plasmid can have multiple replicons, hence the 
number of different plasmids in a sample is not necessarily directly related to the number 
of replicons found. 
Additionally, plasmid multi locus sequence typing (pMLST) can be used to classify 
plasmids further (10, 63). Using pMLST the most common Inc groups are divided into 
different subgroups. Here primers are designed to target additional sites along the 
plasmid, including genes involved in plasmid maintenance and transfer, resulting in a 
more precise characterization. Furthermore, PCR can be used to target a specific gene of 
interest, for example a gene known to encode antibiotic resistance. In order to ensure that 
the gene is present, multiple primers are used, targeting different positions along the same 
gene. 
Finally, there is the option of DNA sequencing for plasmid characterization. There are 
many different approaches for sequencing of DNA molecules (11, 64, 65), but most of 
them follow the same basic principles. First, the DNA is fragmented into smaller pieces, 
normally from ten up to a couple of hundreds of bp in size (66). The fragments are then 
amplified using PCR, and later sequenced individually. In order to obtain the full DNA 
sequence, these fragments, termed reads, need to be assembled. By generating many 
copies of the DNA sequence of interest, and relying on the fragmentation process to be 
random, the idea is that there will be an overlap between different reads, making them 
possible to puzzle back together. 
If the correct sequence can be assembled, DNA sequencing provides information about a 
plasmid down to the base pair level, allowing accurate size estimation as well as 
information about which genes the plasmid harbors. For reliable results, a general 
guideline is that each nucleotide should be sequenced a number of times, referred to as 
coverage, requiring multiple copies of identical plasmids in order to assemble the 
sequence with high accuracy. New technologies (67), relying on high quality samples, 
have made it possible to generate longer read lengths, aiding in the process of assembling 
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intact plasmids (68), a process which is far from trivial due to the dynamic nature of 
plasmids. 
2.3 Antibiotic Resistance 
“The thoughtless person playing with penicillin treatment is morally responsible for the death of the 
man who succumbs to infection with the penicillin-resistant organism” 
– Sir Alexander Fleming, 1945 
Antibiotics are antimicrobial drugs commonly used to treat, and prevent, bacterial 
infections. Starting with the discovery of penicillin by Fleming almost a century ago (1, 
2), antibiotics have become a corner stone of modern health care. However, severe 
overuse, both for humans as well as for livestock, in combination with no new major 
antibiotic discoveries the past decades, has led to a radical increase in the degree of 
resistant bacteria worldwide (3, 4). If the development continues, the prognosis is one 
person dying every third second due to non-treatable bacterial infections by 2050, even 
outcompeting the death rates of cancer globally (3). 
To reverse the trend, there is a need to target the problem on multiple fronts (3). New 
antimicrobial drugs need to be developed, either via compounds similar to the traditional 
antibiotics used today, or by novel strategies including phage therapy, antibodies and 
antimicrobial peptides (69). The use of existing antibiotics needs to be drastically 
decreased via actions such as increased public awareness, improved hygiene and sanitary 
routines, as well as new policies for the use of antibiotics in agriculture and the 
environment. Finally, there is an urgent need for tools capable of rapid diagnostics of 
resistant bacteria. At present, diagnostics of bacterial infections are based on empirical 
observations as well as culture-based approaches (Figure 8). Diagnostics via bacterial 
cultivation in presence of different types of antibiotics is an inherently time consuming 
process, spanning over more than 36 hours, and is further hampered by pathogenic 
bacteria frequently failing to grow in samples from patients with clinical signs of infection 
(5). Rapid diagnostics would not only be beneficial for a patient with a severe bacterial 
infection, but also allow to use existing antibiotics more efficiently, sparing the use of last 
resort antibiotics to when they are truly needed. 
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Figure 8: Schematic flowchart of present and desired paths for bacterial diagnostics. 
 
As discussed above, one of the main reasons for the rapid spread of antibiotic resistance 
is bacterial plasmids (8, 12, 70). The ability of a plasmid to transfer between different 
strains and species via a process known as conjugation, a type of horizontal gene transfer 
(Section 2.3.2), as well as their very dynamic nature, have made plasmids highly 
advantageous for acquiring antibiotic resistance genes. Recently, plasmid mediated 
resistance has been reported for last resort antibiotics, such as polymyxins (71) and 
carbapenemes (70), emphasizing the need of efficient methods to monitor and study 
plasmids. 
2.3.1 Mechanisms of Defense 
Antibiotic resistance can be obtained through spontaneous mutations, or acquired via 
horizontal gene transfer. The outcome of treating a bacteria with an antibiotic which it 
has acquired a resistance gene against will be the same, however the resistance 
mechanism encoded by the gene can differ. Four main defense mechanisms of bacteria to 
antibiotics are shown in Figure 9 (56, 72, 73). 
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Figure 9: Illustration showing four main bacterial defense mechanisms against antibiotics. Circular 
path in the center of the image represents a plasmid encoding resistance via: modification of drug 
target (green), altered cell wall composition (blue), utilization of cell wall attached protein pumps 
(yellow) and enzymatic degradation (red). 
 
Each antibiotic is designed to specifically target a part of an essential process for long term 
bacterial survival. The antibiotic usually targets a structural component within the 
bacterial cell, such as a protein, altering its function, and hence altering the process the 
protein is involved in. By changing the motif the antibiotic is designed to bind, but which 
does not change the function of the bacterial component itself, the effect of the antibiotic 
is neutralized. Other approaches the bacteria can use as defense include alteration of the 
cell wall, hindering the antibiotic from entering, as well as utilizing cell wall proteins 
capable of removing the antibiotic ones it has entered the cell. 
Finally, the bacteria can also produce enzymes capable of altering, or degrading, the 
antibiotic. One example of such enzymes are β-lactamases, with the ability to degrade 
antibiotics belonging to the group of β-lactams, including penicillin. β-lactam antibiotics 
interfere with the cell wall synthesis of the bacteria, both by resource depletion and by 
inhibiting the synthesis process (74). However, if the β-lactamase enzyme cleaves the β-
lactam ring of the antibiotic, the activity is lost and the bacteria is left unharmed. 
2.3.2 Gene Transfer 
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There are two main modes of how resistance genes can be transferred, vertically and 
horizontally (73). Vertical transfer is when a spontaneous mutation occurs, rendering a 
progeny slightly different than its ancestor. Far from all mutations will provide a selective 
advantage, but by chance a minor fraction of them will allow the bacteria to increase their 
fitness compared to their previous generation. In contrast, horizontal gene transfer is a 
process in which foreign genetic material is acquired by a bacterium. There are three main 
mechanisms of horizontal gene transfer: transformation, transduction and conjugation 
(73, 75). Transformation is a process in which foreign material is taken up by a bacterium 
from the surrounding environment. In transduction, DNA is transferred via 
bacteriophages, which are bacterial viruses, inserting their DNA into the bacterial 
genome. Lastly, entire plasmids can be transferred from one bacterium to another in a 
process known as conjugation (Figure 10) (57, 73, 75, 76). 
 
 
Figure 10: The process of conjugation, transfer of a plasmid from a donor cell to a recipient. Image 
depicts pili (blue), responsible for cell to cell contact, and key enzymes, DNA-polymerase (yellow), 
transferase (red) and relaxase (green), involved in the replication and transfer mechanism. 
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Conjugation is a contact dependent process, aided by a pilus on the donor bacterium, 
which attaches to the cell wall of the recipient. The DNA polymerase replicates the 
plasmid in order for both the donor and recipient to end up with a copy. Additionally, 
two protein complexes, transferasomes and relaxomes, assist in the simultaneous transfer 
mechanism (76). Due to the number of genes required for a plasmid to be transferred, 
conjugative plasmids tend to be larger than 30 kbp (7). Since the entire plasmid is 
transferred, a plasmid harboring resistance genes against a variety of antibiotics, can 
make a fully susceptible bacterium multi resistant in one step. 
2.4 Optical DNA Mapping 
Optical DNA mapping is based on visualizing long range sequence information on 
individual DNA molecules at the kbp level. The DNA is labeled in a sequence specific 
manner, stretched, and finally imaged, generally using a fluorescence microscope. 
Advantages of using optical mapping to study DNA include remarkable read lengths, 
spanning up to 1 Mbp, as well as extracting information on single molecule fluctuations, 
avoiding averaging. Below follows a brief overview of the progress which has been made 
within the filed, including strategies for labeling and stretching of DNA.  For a more 
detailed description the reader is referred to the following reviews (15, 16, 77-81). 
Since the pioneering work by Schwartz et al. (14), utilizing restriction enzymes to cut the 
DNA molecules at specific sites, and subsequently visualizing the length of the different 
fragments in an agarose gel, the field of optical DNA mapping has advanced significantly. 
Different approaches for stretching and labeling have been developed. Main techniques 
for extending DNA include molecular combing (82, 83), were DNA is stretched on 
modified glass surfaces, as well as nanofluidic devices (84), in which DNA is extended by 
confinement to nanofluidic channels. Labeling strategies can be divided into two main 
categories, enzyme based labeling, and affinity based labeling, illustrated in Figure 11. 
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Figure 11: Schematic illustration of the most common labeling strategies for optical mapping of 
DNA. Top Left: Nick labeling, where a nicking enzyme creates a single strand break at its recognition 
site, typically 4-7bp long. A DNA polymerase later removes old, and incorporates new fluorescently 
labeled, nucleotides, in order to visualize the site. Top Right: Methyltransferase based labeling, where 
a fluorescently labeled methyl group is transferred to the DNA at a specific recognition site. Bottom 
Left: Denaturation mapping, utilizing the lower melting temperature of AT base pairs compared to 
GC base pairs. Staining the DNA with the fluorescent dye YOYO, which prefers dsDNA over 
ssDNA, and carefully increasing the temperature, will result in dissociation of YOYO subsequent 
to the local melting of AT base pairs. Bottom Right: Labeling via competitive binding between the 
AT specific, non-fluorescent, molecule netropsin and YOYO. Netropsin will bind to AT sites, 
blocking these from YOYO, creating an emission profile along the DNA where AT-rich regions are 
dark, and GC-rich regions bright. 
 
Introduced by Jo et al. (85), nick labeling is based on incorporating fluorescently labeled 
nucleotides at sequence specific sites (Figure 11). First, a nicking enzyme generates a 
single stranded break, referred to as nick, at its recognition site, typically 4-7 bp long. 
Next, a DNA polymerase is used to remove, and subsequently incorporate, new 
fluorescently labeled nucleotides along the strand. In order to determine the start and end 
of each molecule, YOYO is used to stain the full contour of the DNA molecule. Depending 
on the sensitivity of the application, the DNA can be repaired from any existing nicks 
previous to the assay, avoiding false positives, and excess nucleotides removed 
afterwards, in order to decrease the background fluorescence. 
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Das et al. later extended the nick labeling assay, introducing a nick-flap labeling scheme 
(86). By using a DNA polymerase lacking exonuclease activity, the nucleotides following 
the nicking site are displaced rather then removed, leaving a single stranded flap of DNA. 
This allows for dual labeling, including the nicking site, as well as the flap, using a 
complementary, labeled, oligonucleotide. Moreover, Hastie et al. used a dual labeling 
approach, using two nicking enzymes with different recognition sites (87). Performing 
the reactions consecutively, with an intermediate purification step, allowed the use of 
differently labeled nucleotides and thus a dual color readout. In order to address the 
limited specificity of the available nicking enzymes, McCaffery et al. further extended the 
nick labeling assay using a CRISPR/Cas9 based approach, enabling the use of a highly 
adaptable 23 bp long recognition site (52). Nick labeling, in combination with 
nanochannel based DNA extension, has been commercialized via BioNanoGenomics, 
allowing for a range of applications, including de novo assembly of complex genomes 
where the optical maps are used as templates (88-99). 
Similar to nick labeling, methyltransferases can be used in order to label DNA in a 
sequence specific manner (100, 101). The enzyme recognizes a site, typically 4 bp, and 
transfers a fluorescently labeled methyl group to the DNA (Figure 11). Vranken et al. used 
this approach to achieve optical maps with nanometer resolution (102). Methyltransferase 
labeling has also been used to generate densely labeled DNA, termed amplitude 
modulation profiles, taking advantage of the short recognition site of the enzyme (103). 
Additional to nick and methyltransferase based labeling, there is also the possibility to 
extract information beyond the DNA sequence. Applications include epigenetic marks in 
the form of methylations (104), and hydroxymethylations (105, 106), as well as histone 
modifications (107). Furthermore, DNA damage sites have been successfully 
fluorescently labeled and visualized after stretching the DNA molecules on a glass surface 
(108). 
Denaturation mapping, developed by Reisner et al. (109), utilizes the lower melting 
temperature of AT base pairs, which are connected by two hydrogen bonds, compared to 
GC base pairs, which have three hydrogen bonds. By staining the entire DNA contour 
with the fluorescent dye YOYO and carefully increasing the temperature, AT base pairs 
will melt, causing YOYO, which prefers dsDNA over ssDNA, to dissociate. This will 
create an emission intensity profile along the extension of the DNA, where AT-rich 
regions will be dark, and GC-rich regions bright. The DNA can be heated either on chip 
(109, 110), or before sample loading (111). 
24 
 
Recently, a complementary approach for labeling DNA, based on competitive binding, 
has been established (112, 113). When simultaneously adding the AT specific, non-
fluorescent, molecule netropsin, and the fluorescent dye YOYO, the molecules will 
compete for the binding sites on the DNA. If added in a correct ratio, netropsin will block 
the AT-sites, preventing YOYO to bind, rendering an emission intensity profile along the 
DNA, where AT-rich regions will appear dark, and GC-rich regions bright. With the 
competitive binding assay, which has been used throughout the work presented in the 
Thesis, there is no need for repair of the DNA before labeling, performing additional 
purification steps, or achieving precise temperature control.
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3 Methodology and Fundamental Concepts 
 
In this section, the methods used in the Thesis are described, as well as some related 
fundamental concepts. First, a brief theory on the emission of light is provided that is later 
coupled to a description of fluorescence microscopy. Background is also given on the 
concept of DNA in nanofluidics, including chip design and experimental setup. 
3.1 Emission of Light 
The interaction between light (photons) and matter will depend on the electronic 
configuration of the irradiated molecules in the sample. The energy of the photons, 
described by their wavelength, can be absorbed by a molecule via the excitation of an 
electron. For excitation to occur, the energy of the photon needs to match the energy gap 
between an excited state of the molecule () and its ground state (). A Jablonski 
diagram, shown in Figure 12, illustrates the different excitation and de-excitation 
processes occurring when a molecule interacts with light. 
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Figure 12: A Jablonski diagram showing absorption and excited state deactivation pathways of a 
molecule. Singlet (,  and	) and triplet () states are shown with bold horizontal lines, with 
corresponding vibrionic states as non-bold horizontal lines. Radiative processes, including 
absorption (blue), fluorescence (green) and phosphorescence (yellow), are displayed as straight 
vertical arrows. The non-radiative processes internal conversion (IC), inter system crossing (ISC) 
and vibrational relaxation (VR) are shown as undulating arrows. 
 
When a photon is absorbed by a molecule, the absorbed energy will lead to a re-
configuration of the electrons within the molecule, resulting in what is referred to as an 
excited state. The excited states, both singlet (), with paired electrons, and triplet (), 
with unpaired electrons, are numbered in a consecutive order based on their energy gap 
relative to the ground state. Each electronic state is also associated with a number of 
vibrational states, which are typically closer in energy. 
Following excitation to , the molecule will typically undergo rapid relaxation to the 
lowest vibrational energy of the first excited state (), via a combination of vibrational 
relaxation and internal conversion. Hence, excited state processes can be approximated 
to only occur from the lowest vibrational state of , a phenomena referred to as Kasha’s 
rule (114). Once in , the molecule can return to the ground state via three main routes: 
non-radiative relaxation, emission from the first excited singlet state () and decay 
through the first excited triplet state (). For non-radiative relaxation, the molecule 
undergoes internal conversion from  to , followed by vibrational relaxation (Figure 
12), dissipating the excess energy to the surrounding environment. Deactivation via 
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radiative relaxation from in  to  is termed fluorescence, and results in an emitted 
photon. Deactivation via  involves inter system crossing, where the molecule undergoes 
a spin-forbidden transition, rendering a state with unpaired electrons. From  the 
molecule can either return to its ground state via emitting a photon, known as 
phosphorescence, of by relaxing non-radiatively (Figure 12). Which deactivation pathway 
that dominates will depend on the structure of the molecule, as well as the surrounding 
environment. 
The wavelength of an emitted photon is typically longer than the wavelength used for 
excitation. For fluorescence, the difference in wavelength is referred to as the Stokes shift 
(115). The Stokes shift can be explained by the rapid relaxation from  to , the tendency 
of a molecule to return to an excited vibrational state of  upon emission, as well as 
excited-state reactions and solvent relaxation effects. The efficiency of the fluorescence 
process is described in terms of the quantum yield, which is a measure of how many times 
a specific event, such as fluorescence, occurs per photon absorbed by the molecule. 
Moreover, the amount of emitted photons will depend on the ability of a molecule to 
absorb light, which is governed by the molar absorptivity () at each wavelength. 
The preferred properties of a fluorescent molecule, a so called fluorophore, vary 
depending on application. In general, a high quantum yield, in combination with a high 
molar absorptivity is desirable, providing a bright fluorophore. Furthermore, a distinct 
Stokes shift allows separation of excitation and emission more efficiently. For instance, 
the fluorophore YOYO, used in the work presented in the Thesis, has a quantum yield of 
0.52, molar absorptivity of 105 M-1cm-1 at 491 nm and an emission maximum at 509 nm 
when bound to dsDNA (33). 
3.2 Fluorescence Microscopy 
Fluorescence microscopy has been extensively used throughout the work presented in the 
Thesis. In contrast to other optical microscopy techniques, relying on reflection and 
absorption, fluorescence microscopy utilizes emission to visualize a substrate. For 
inherently non-fluorescent molecules, such as DNA, a fluorophore can be used to enable 
visualization. The principle setup of an inverted fluorescence microscope is shown in 
Figure 13. 
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Figure 13: Schematic image depicting the main components of an inverted fluorescence microscope. 
 
The main components of a fluorescence microscope include: an excitation light source, 
two filters, one for excitation and one for emission, an objective to focus the light onto the 
sample, as well as a detector recording the emitted photons. The light source can either 
be monochromatic, or contain a broad spectrum of wavelengths. The excitation and 
emission filters are usually combined with a dichroic mirror, possessing the ability to 
reflect excitation light and transmit emitted light. The three components make up a so 
called filter cube, which can be changed in order to match the maximum excitation and 
emission wavelengths of the selected fluorophore. 
In short, light is sent through the excitation filter in order to match the excitation 
wavelength of the fluorophore of interest. The transmitted light is reflected on a dichroic 
mirror and focused through an objective before reaching the sample. The back-scattered 
fluorescence emission is then collected through the same objective and transmitted 
through the dichroic mirror and emission filter before reaching the detector. Detection is 
typically enabled via a sensitive camera, such as a complementary metal oxide 
semiconductor (CMOS) or an electron multiplying charged coupled device (EMCCD).  
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3.3 DNA in Nanofluidic Devices 
There are different approaches for stretching individual DNA molecules, including the 
use of magnetic or optical tweezers, flow, molecular combing, and nanofluidic channels 
(116). For optical DNA mapping, stretching DNA on modified glass surfaces, known as 
molecular combing, or extending DNA in nanofluidic channels, are the most common 
approaches. While molecular combing offers a rapid overview of many molecules, in 
combination with being readily accessible, uniform stretching is not guaranteed. When 
stretching DNA by confinement in nanofluidic channels, a position X% into the contour 
of the DNA will correspond to X% into the sequence, thus allowing sequence specific 
information to be extracted with high precision. Nanofluidic devices also offer the 
possibility of automation, allowing for high throughput applications. 
Utilizing the advances made in the field of microelectronics, techniques for fabrication of 
nanofluidics chips have been established (77). Generally the nanofluidic chips are 
fabricated from oxidized silicon, also known as silica, due to its high availability and 
favorable properties. The low surface roughness and negative charge of the silica prevents 
DNA molecules from adhering to the channel walls. Also, the hydrophilic nature of the 
material promotes wetting once DNA and buffer are added to the chip. The design of the 
nanofluidic chip used for the work presented in the Thesis is shown in Figure 14. 
 
 
Figure 14: Schematics of a nanofluidic chip showing four circular loading wells, connected two and 
two by microchannels, which in turn are spanned by a set of nanochannels (zoom). 
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The nanofluidic chip used for the work presented in the Thesis, and shown schematically 
in Figure 14, has four wells for sample loading, connected two and two via microchannels. 
The microchannels are in turn spanned by a set of nanochannels with dimensions of 100 
x 150 nm (width x height) and a length of 500 µm. The nanofluidic chips are made from a 
500 µm thick silicon wafer using standard clean room procedures including: thermal 
oxidation, photolithography, E-beam lithography, reactive ion etching (RIE) and fusion 
bonding. In order to allow visualization of the DNA inside the nanofluidic channels, the 
chip is sealed with a transparent Pyrex glass lid. 
Over the years, various designs of nanofluidic chips have been demonstrated, tailor made 
for their specific applications. Approaches include, tapered nanochannels allowing to 
measure extension of a DNA molecule at different degrees of confinement (117), entropic 
gradients lowering the entropy barrier by pre-stretching the DNA prior to entering the 
nanochannel (90), as well as meandering channels in order to visualize Mbp sized DNA 
molecules in one single frame (118). Moreover, post processing procedures, such as lipid 
passivation (119), are available and can prevent proteins and other biological molecules 
from adhering to the channel walls. For more details on the fabrication process of 
nanofluidic chips the reader is referred to the following reviews (23, 77, 120). 
In order to visualize and image the DNA when confined in the nanofluidic channels an 
experimental set-up based on fluorescence microscopy, as schematically shown in Figure 
15, was used for the work presented in the Thesis.  The chip is mounted onto a chip holder 
which in turn is placed on the microscope. Besides functioning as a support for placing 
the chip in contact with the objective of the microscope, the chip holder provides access 
to the loading wells of the chip, allowing to add the sample, as well as to move the DNA 
inside the chip via the use of pressure driven N2 flow. A 100x oil immersion objective with 
numerical aperture of 1.46 in combination with an EMCCD camera was used for imaging. 
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Figure 15: Left: Illustration of the experimental setup used for the research presented in the Thesis. 
The EMCCD camera is shown in green, the fluorescence lamp in blue, the bright field lamp in yellow 
and the chip holder in red.  Right: Schematics of the chip holder with the nanofluidic chip mounted 
underneath (bottom), inlets for sample loading (top) and connections for applying pressure to specific 
loading wells (side). 
 
  
32 
 
 
33 
 
4 Summary of Results 
 
In this chapter, the work on which the Thesis is based will be discussed and summarized. 
An overview of the results presented in the appended papers is provided, starting with a 
brief introduction to the developed assay, followed by some general information on the 
experimental procedure and subsequent data analysis. For further details on the 
presented research, the reader is referred to the appended papers. 
4.1 Assay Development 
As previously discussed, one of the main reasons for the rapid spread of antibiotic 
resistance is horizontal gene transfer of mobile genetic elements, such as plasmids. 
Therefore, tools allowing the epidemiology and evolution of plasmids to be studied are 
of great interest. Moreover, there is an urgent need for rapid POC diagnostics in order to 
enable more efficient treatment of serious bacterial infections, as well as to spare last resort 
antibiotics to when really needed. 
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To meet this need, an assay was developed for rapid characterization of intact plasmid 
molecules, based on the previously established competitive binding scheme of YOYO and 
netropsin (112, 113). The advantage of optical DNA mapping compared to existing 
strategies for plasmid analysis include the low amount of sample required, as well as 
obtaining long range sequence information from the intact plasmid sequence. An 
overview of the current version of the assay, developed in Paper I-III, can be seen in 
Figure 16. 
 
 
Figure 16: Overview of the assay developed in Paper I-III. In the first step the plasmid is cut by Cas9 
(red scissors) at the site of the targeted gene. In the second step, YOYO (green star) and netropsin 
(gray rectangle) are added to the sample, creating an emission intensity profile along the DNA based 
on the underlying sequence. In the third step, nanofluidic channels are used to stretch the DNA, 
allowing the emission profile along the contour of the DNA to be visualized using fluorescence 
microscopy. Following the data analysis, the size of all plasmids, a corresponding “fingerprint” for 
identification and tracking, as well as information on the presence or absence of a specific gene is 
acquired. 
 
The work presented in Paper I (details in Section 4.2) allowed us to identify plasmids 
encoding genes for antibiotic resistance by comparing to a database containing all known 
plasmid sequences. In Paper II (details in Section 4.3) we were able to identify and trace 
plasmids in clinical samples from a nosocomial outbreak at a neonatal ward at 
Sahlgrenska University Hospital. Moreover, using an approach based on CRISPR/Cas9, 
we demonstrated in Paper III (details in Section 4.4) how the assay could be expanded to 
simultaneously detect (resistance) genes on individual plasmids. 
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In short, the assay, as illustrated in Figure 16, shows how the resistance gene is selectively 
cut by the Cas9 enzyme, before subsequent staining with YOYO and netropsin. The DNA 
is later stretched in nanofluidic channels, allowing for visualization using fluorescence 
microscopy. Finally, analysis of the data reveals the number of plasmids in the sample, 
their corresponding size and sequence specific intensity profiles, as well as the presence 
or absence of a targeted gene. 
4.1.1 Experimental Procedure 
In this section, some general considerations of the experimental procedures for the three 
presented papers are provided, beginning with the plasmid samples that have been 
provided by our collaborators at Uppsala University and Sahlgrenska University 
Hospital. Following cultivation of clinically relevant bacterial isolates, the plasmids were 
extracted using standard commercialized kits. First the DNA was separated from the 
additional components of the bacterial cell, followed by separation of the circular 
plasmids from the chromosomal DNA. 
The plasmid samples were stained using an approach based on competitive binding 
between YOYO and netropsin, as described in Section 2.4 (112, 113). In short, the non-
fluorescent, AT-specific, molecule netropsin, competes with the fluorescent dye YOYO 
for the AT-rich regions, resulting in an overall lower emission from AT-rich regions than 
from GC-rich regions along the extension of the DNA molecule (Figure 17). In order to 
compensate for the lower overall binding affinity to DNA, netropsin was generally added 
at a ratio of 150:1 with respect to YOYO. The obtained intensity profile serves as a 
“fingerprint” for the DNA molecule, based on the underlying sequence (Figure 17). 
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Figure 17: Schematic illustration of the emission intensity profile created by the competitive binding 
of YOYO (green star) and netropsin (gray rectangle) to DNA, serving as a “fingerprint” of the 
underlying DNA sequence.  
 
In addition to YOYO and netropsin, lambda DNA was added to the plasmid sample as 
an internal size reference. The size of the linear lambda DNA molecule (48 502 bp) is 
previously known, allowing a conversion factor to be calculated, relating the extension in 
pixels to the number of bp of an observed plasmid. Since lambda DNA was added to each 
plasmid sample, it was possible to compensate for minor deviations in the experimental 
conditions, including factors such as ionic strength and nanochannel dimensions. 
In order to facilitate rapid equilibration, the DNA was stained with YOYO and netropsin 
at high ionic strength and heated to 50 °C (121). The high ionic strength shields the 
negatively charged DNA backbone, increasing the rate of dissociation of the positively 
charged YOYO molecule, facilitating rapid rearrangement along the DNA. However, as 
previously discussed in Section 2.1.2, a high ionic strength will decrease the degree of 
extension of DNA when confined to nanofluidic channels (77). Therefore, subsequent to 
the labeling, the sample was diluted approximately 100 times with ultrapure water, 
providing a solution of much lower ionic strength. 
When exposing YOYO to light in the presence of oxygen, oxygen radicals will be formed, 
capable of producing single strand breaks on the DNA (122), a process referred to as 
photo-nicking. If two single strand breaks occur close enough on each of the DNA strands, 
the dsDNA will break. In order to reduce the amount of photo-nicking, the oxygen radical 
scavenger β-mercaptoethanol (BME) was added to the solution. 
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As briefly mentioned in Section 3.3, an epi fluorescence microscope, allowing access to 
the chip from below, with the objective facing the glass lid of the chip, was used for the 
work presented in the Thesis. The use of a 100x oil immersion objective with a numerical 
aperture of 1.46, in combination with an EMCCD camera, sets a resolution limit on the 
optical DNA maps of typically 1 kbp. The resolution is limited by the dimensions of the 
nanochannels, governing the degree of extension, as well as the fundamental resolution 
limit of optical microscopy. An image of plasmids inside the micro and nanochannels of 
the chip, visualized with fluorescence microscopy, is shown in Figure 18. 
 
 
Figure 18: Fluorescence microscopy image of one plasmid inside the larger microchannel (50 µm x 
850 nm), and three plasmids confined inside the narrower nanochannels (100 nm x 150 nm). 
 
In order to control the movement of the DNA inside the nanofluidic chip, a N2 flow system 
was used. The rationale for using N2 in the flow system, rather than air, was to reduce the 
overall concentration of O2 in the sample, preventing extensive photo-nicking of the DNA. 
By connecting one switch to each loading well, DNA can be flushed inside the 
microchannel by applying pressure to one of the wells, and subsequently forced into the 
nanochannels, by applying pressure to both sides of the microchannel (Figure 14, 15 and 
18). Once confined, a series of typically 200 images, with an exposure time of 100 ms, was 
taken of the extended DNA molecules. 
 
38 
 
4.1.2 Data Analysis 
The data analysis tools used for the work presented in the Thesis have been developed in 
collaboration with Tobias Ambjörnsson’s group at Lund University. The Matlab based 
software has been continuously improved throughout the presented work, adding new 
features for each appended paper. An overview of the data analysis workflow can be seen 
in Figure 19. 
 
 
Figure 19: Work flow over the data analysis steps used in the work presented in the Thesis. 
 
Following data acquisition, the DNA molecule is detected and collapsed into a one-
dimensional (1D) image, containing the mean intensity value for each pixel along the 
extension of the molecule. The DNA molecule is detected for each individual time frame, 
and the obtained 1D images are stacked underneath each other, creating a kymograph 
(Figure 20). By detecting the edges of the DNA molecule for each time frame in the 
kymograph, the average extension can be calculated. 
In order to extract the sequence specific information from the kymographs, molecule 
fluctuations, as well as drifting, inside the nanofluidic channels need to be considered. 
This is done by applying an algorithm, allowing the features of the kymograph to be 
aligned (123). In short, the edges are traced and shifted to the same position, ensuring that 
the extension of the molecule in each frame is the same. Next, the most pronounced bright, 
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or dark, feature, is detected and aligned by stretching each row in the kymograph 
separately. The newly aligned feature is fixed, and the process is repeated until the 
regions separating the fixed pixels are considered small enough. In order to obtain the 
final average intensity trace, referred to as a barcode, the mean value of each column in the 
aligned kymograph is calculated and plotted against the extension (Figure 20). In order 
to account for experimental differences in overall kymograph intensities, the intensity 
traces are normalized, with the average value set to 0, and standard deviation to 1. 
 
 
Figure 20: Illustration of the main processing steps of the raw data. First, the molecule is detected in 
each individual time frame, where each frame is represented as a one-dimensional image containing 
the mean intensity along the extension of the molecule. The one-dimensional images are then stacked 
underneath each other in order to create a kymograph. The kymograph is aligned in order to account 
for molecule fluctuations and drifting inside the nanofluidic channels. Finally, the mean value is 
calculated for each column in the aligned kymograph, resulting in an average intensity trace along 
the extension of the molecule, which can serve as a fingerprint for plasmid identification. 
 
The barcode from each individual plasmid molecule can serve as a fingerprint of the 
underlying sequence. However, to remove any inconsistencies arising from experimental 
noise, barcodes originating from the same plasmid sequence can be averaged into a 
consensus barcode. When linearizing the circular plasmids (details in Section 4.2-4.4), the 
position of the double strand break can differ, causing the linear fragments to be circularly 
permutated. In order to account for a potential relative shift in the barcodes of two 
individual plasmids, a cross-correlation (Ĉ) value is calculated. 
The cross-correlation value puts a number on the similarity of two barcodes, where a 
value of +1 is the maximum, implying that the barcodes are identical, and a value of -1 is 
the minimum. The value is calculated by multiplying the intensity value of each pair of 
pixels from two individual barcodes, adding these together, and finally normalizing. 
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When comparing two barcodes, one will be fixed, and the other one shifted one pixel at 
the time, allowing the cross-correlation for each possible starting position to be calculated. 
Repeating the procedure for the flipped version of one of the barcodes enables the 
maximum cross-correlation for a pair of barcodes to be found. 
The process of generating a consensus barcode can be seen in Figure 21. First, all barcodes 
are stretched to the same length, followed by calculating the maximum cross-correlation 
value for all possible pairs of barcodes. The two barcodes that display the highest cross-
correlation value will then be merged at the position of the optimal shift, and possible 
flip, representing an average of the two individual barcodes. Next, the process is repeated, 
with the new average barcode replacing the two individual ones. Once again, the two 
barcodes showing the highest degree of similarity will be merged, and the process is 
repeated until only one consensus barcode remains. 
 
 
Figure 21: Illustration of the process where individual barcodes are gradually merged, based on their 
degree of similarity, resulting in a final consensus barcode. The number at each line corresponds to 
the weight of the barcodes as they are merged. 
 
The obtained consensus barcodes were used to either identify a plasmid from a data base 
of previously sequenced plasmids (Paper I), or to trace the spread of a plasmid in an 
outbreak (Paper II). In order to enable the comparison of an experimental consensus 
barcode to known DNA sequences, theoretical barcodes were generated. Moreover, a 
statistical measure, termed separability-score, allowing to compare if a match to the 
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database was significant or not was defined. Similarly, a method for obtaining a statistical 
measure for the similarity between two experimental consensus barcodes was developed, 
rendering a p-value as output. Finally, in Paper III, a “balls in boxes” approach was used to 
determine if the maximum number of double strand breaks at a certain position along the 
plasmid contour could be deemed significant, allowing the presence of a resistance gene 
to be detected. 
4.2 Identifying Plasmids from a Sequence Database 
The aim of the study presented in Paper I, was to investigate the possibility to identify 
plasmids by comparing experimental barcodes to a database of theoretical barcodes. The 
previously established competitive binding protocol (112, 113), was adapted to plasmids, 
and evaluated using the three sequenced and well characterized plasmids, RP1 (60.1 kbp), 
R100 (94.3 kbp) and pUUH 239.2 (pUUH) (220.8 kbp), all encoding genes for antibiotic 
resistance. The circular nature of the plasmids provided both advantages, as well as 
challenges, when designing the assay. The ability to discriminate a circular plasmid from 
linear pieces of DNA (124, 125), ensured that only intact plasmid sequences were studied. 
However, in order to reveal the sequence specific pattern, the circular plasmids needed 
to be linearized. Using intense light exposure, reactive oxygen species were obtained 
(Section 4.1.1), capable of causing single strand breaks on the confined circular DNA. 
Once two singe stranded breaks occurred close enough to each other, the plasmid 
unfolded to its linear configuration. 
To compare an experimental barcode to a DNA sequence, theoretical barcodes were 
generated (113). In short, the theory barcodes were created by considering the likelihood 
of YOYO and netropsin to bind a four bp site along the DNA sequence, and compensating 
for the resolution limit set by the experimental setup. Mainly, experimental consensus 
barcodes, generated from a number of individual barcodes, were used for the comparison 
with the theoretical barcodes from the database. Moreover, the consensus barcode of a 
plasmid was only compared to the plasmids from the database corresponding to a size of 
+/- 3 standard deviations (STD) from the experimentally measured size. 
For the R100 plasmid, the experimental consensus barcode and the theory barcode 
showed a high degree of similarity, with a Ĉ-value above 0.9 (Figure 22, left). When 
comparing the consensus barcode to all theory sequences of +/- 3 STD in size, two 
plasmids were clearly separated from the rest in terms of Ĉ-value, R100 and NR1, where 
the latter is a variant of R100 with 99.8% sequence similarity (Figure 22, right). 
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Figure 22: Left: Comparison of the experimental consensus barcode (gray) of plasmid R100 with the 
corresponding theoretical barcode (black). Right: Histogram showing the best cross-correlation value 
obtained when comparing the experimental consensus barcode of R100 with all theoretical barcodes 
of +/- 3 STD in size from a database of all theoretical barcodes. The solid line corresponds to the 
Gumbel fit of the obtained data. The arrow indicates the cross-correlation value obtained for the 
correct sequence. 
 
For the shorter plasmid, RP1, a high degree of visual similarity, as well as a Ĉ-value above 
0.8, was obtained when comparing to the theoretical RP1 barcode. However, even if the 
Ĉ value for the correct sequence was in the top 0.005 fraction, it was not clearly separated 
from the rest of the theoretical barcodes. The lower separability of RP1 compared to R100 
can be partially explained by the shorter sequence, resulting in a less unique barcode, as 
well as by the lower Ĉ-value. For the third, and largest plasmid, pUUH, an inverted region 
of the sequence was found when comparing the consensus barcode with the theoretical 
barcode (Figure 23). Investigation of the DNA sequence revealed that the inverted region 
contained a cassette of resistance genes, flanked by transposable elements, capable of 
generating the inversion. The presence of the inversion was later confirmed with PCR. 
The Ĉ-value of the consensus barcode compared to the theoretical barcode increased from 
0.78 to 0.91, when correcting for the inverted sequence, clearly separating the correct 
sequence of the pUUH plasmid from the rest of the theoretical plasmid barcodes in the 
database. 
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Figure 23: Experimental consensus barcode (gray) compared to the theoretical barcode (black) for 
the plasmid pUUH 239.2. The gray box indicates the inverted region of the sequence. 
 
In order to generalize the results, an in silico comparison of all 3127 plasmids above 20 
kbp from the NCBI RefSeq database, differing less than 20% in size, was made. A 
separability-score, similar to a traditional p-value, was introduced in order to provide a 
statistical significance for each well separated plasmid sequence.  The results showed, 
using a separability-score of 0.01, that plasmids larger than about 70 kbp should be 
possible to identify using the assay, with an extreme lower limit of 30 kbp, depending on 
the uniqueness of the barcode. 
In summary, Paper I, demonstrates that it is possible to identify clinically relevant 
plasmids by comparing experimental barcodes to a database of theoretical barcodes. The 
assay enables the intact sequence of individual plasmids to be studied and has the 
potential to detect structural variations. 
4.3 Tracing Plasmids during an Outbreak 
In contrast to Paper I, where the barcode of the plasmid was used for identification, we 
in Paper II investigated how the size of the plasmid, in combination with the barcode, 
could be used to trace plasmids originating from a nosocomial outbreak at Sahlgrenska 
University Hospital (126). Under the four month long outbreak in 2008, over 20 neonates 
were infected with multi-resistant bacteria, harboring extended spectrum beta-lactamase 
(ESBL) genes. The main strain of the outbreak was found to be an E. coli of sequence type 
(ST) 131 (126). However, two additional E. coli strains, ST73 and ST1444, were identified, 
as well as a K. Pneumoniae strain. Both E. coli and K. Pneumoniae belong to the family of 
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Enterobacteriaceae, which are well known to express ESBLs (70, 127, 128). Moreover, ESBL 
mediated resistance is frequently located on plasmids (129-131), thus the outbreak was 
suspected to be plasmid-born. However, it was not known if there in fact were multiple 
outbreaks occurring simultaneously, indicated by the presence of different types of 
bacterial strains and species, or if the outbreak was mediated by the transfer of a single 
plasmid between different bacteria. 
The aim of the study presented in Paper II was to trace plasmids from the outbreak, by 
both monitoring plasmid content over time, and detecting the spread of plasmid between 
bacterial strains and species, as well as between patients. Unlike in Paper I, were 
experimental consensus barcodes of previously well characterized plasmids were 
compared to a database of theoretical barcodes, a method for comparing two 
experimental consensus barcodes with each other was developed in Paper II. In short, 
statistical information from all theoretical barcodes in the plasmid database was 
extracted. Based on this information, randomized barcodes were generated, acting as a 
reference model in order to convert the obtained Ĉ-value, which is size dependent, to a 
p-value. 
In total, 9 isolates, originating from 4 different neonates, were selected for the study, 
including isolates from all different strain types, as well as isolates sampled at different 
time points. The detected plasmids were characterized by size and barcode. The size of 
all the plasmids found in the 9 different isolates was obtained by measuring the extension 
of the plasmids in their circular form (124, 125), with results shown in Figure 24. 
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Figure 24: Top: Histogram showing the measured size of each detected plasmid in the different 
isolates, including E. coli of strain types (ST) 131, 71 and 1444, as well as a strain of K. Pneumoniae 
(Kleb). The isolates are indexed by the patient number (PX) followed by a letter in order to 
discriminate isolates originating from the same patient. Bottom: Comparison of experimental 
consensus barcodes for the common plasmid found in isolate P1a and P1b, as well as P3a and P3b. 
 
The size measurements revealed a plasmid of similar size shared by all the isolates, 
ranging between 73-90 kbp in size, indicating that this plasmid was responsible for the 
spread of resistance. When studying the barcodes of the shared plasmid, they all showed 
a high degree of visual similarity. Moreover, by computing the p-value for all different 
pairs of plasmids, the results showed that the plasmids indeed displayed a statistically 
significant degree of similarity. Using the p-value tool when comparing two experimental 
consensus barcodes furthermore allowed the shared plasmid to be divided into two 
different subgroups, one displaying an extra insert at a specific position along the 
sequence, and one group without this insert (Figure 24). The extra piece in the DNA 
sequence in some of the plasmids also explains the differences in measured size. An 
overview of the findings when studying the plasmid content in all selected isolates can 
be seen in Figure 25. 
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Figure 25: Schematic illustration of the results obtained from the study presented in Paper II. 
Patients are represented by green circles, and individual isolates are shown in blue. The red circle 
corresponds to the unknown route of transmission. 
 
In summary, a shared plasmid of about 80 kbp in size with a highly similar barcode was 
found in each of the studied isolates, indicating that this plasmid was responsible for the 
spread of resistance. The results demonstrate the possibility of the assay to monitor 
plasmid content over time, detect the spread of plasmids between different bacteria 
strains and species, as well as indicating the transfer of bacteria between patients. The 
study shows how conclusions regarding the spread of resistance can be made, without 
knowing the sequence of the plasmid. Hence, the method shows great potential to 
provide guidance at an early stage during an outbreak situation, pinpointing which 
isolates that subsequently require a more detailed characterization. 
4.4 Gene Detection 
One of the main limitations of the assay presented in Paper I-II, was the inability to 
directly detect the presence of resistance genes. Using the outbreak studied in Paper II as 
an example, a modified assay allowing to pinpoint the resistance gene directly to the 
shared plasmid, in Paper II confirmed via subsequent PCR, would be highly desirable. 
Moreover, using the barcode to detect the presence of a resistance gene would not only 
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allow the assignment of the gene to a specific plasmid, but also to a precise location along 
the sequence. 
With that goal in mind, Paper III demonstrated the development, and evaluation, of a 
novel assay for detecting resistance genes on single plasmids, utilizing the high sequence 
specificity of the Cas9 enzyme. By designing a crRNA sequence complementary to the 
gene of interest (Section 2.1.4), a plasmid harboring the gene will be “cut” at a specific 
location. Studying the positions of the double strand breaks along the barcodes of 
individual plasmids, enables determination of if a vast majority of the cuts have occurred 
at the same position along the sequence (Figure 26). By introducing a “balls in boxes” 
approach, the number of double strand breaks that by random chance would be expected 
to occur at the same position along the barcode can be simulated. A detection limit of + 3 
STD of the obtained value enables the detection of a gene, provided that enough cuts have 
been observed at the same position. 
In contrast to Paper I-II, circular plasmids were in Paper III not broken with light in order 
to reveal the barcode. Instead, circular plasmids were used solely for size determination, 
and pre-linearized plasmids were imaged in the nanochannels. For analysis, only linear 
fragments +/- 20% of the detected circular plasmids were analyzed, and the positions of 
the double strand breaks of the corresponding consensus barcodes were determined in 
order to detect the presence, or absence, of the gene of interest. In short, the number of 
linearized plasmids which encode the gene targeted by Cas9 will be high, consisting of 
mainly Cas9 cut plasmid molecules, but also include some which have been randomly 
linearized via mechanical stress or light exposure. In contrast, the number of fragments 
from a plasmid not harboring the targeted gene will be low, only containing randomly 
linearized plasmid molecules (Figure 26). 
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Figure 26: Schematic illustration of the Cas9 assay. While a double strand break introduced by the 
Cas9 enzyme (red scissors), loaded with crRNA targeting the gene of interest, will be site specific, a 
break caused by light or mechanical stress (yellow lightning) will be randomly positioned along the 
contour of the plasmid. Hence, if the targeted gene is present (right), all linear fragments will have, 
within the experimental noise, identical barcodes. In contrast, if the targeted gene is not present (left), 
the linear fragments will be circularly permutated, broken only by light or mechanical stress. 
 
The principle of the assay was demonstrated on the previously sequenced plasmid 
pUUH, harboring the common ESBL gene blaCTX-M-15. When adding crRNA with a 
sequence complementary to the blaCTX-M-15 gene, a vast majority of the double strand 
breaks occurred at the predicted position along the sequence, thus confirming the 
presence of the gene. Similar results were obtained for other plasmid isolates, containing 
either one, or multiple plasmids, demonstrating the assays ability to not only detect the 
presence of resistance, but also to pinpoint it to a single plasmid. 
As a final test, two previously uncharacterized plasmid isolates, DA28170 and D49173, 
were studied. Adding a cocktail consisting of two specifically designed crRNA molecules 
to the samples, it was possible to simultaneously target two of the main genes groups, 
blaKPC and blaNDM, encoding for carbapenem resistance. For isolate DA49173, the results 
revealed the presence of two plasmids in the sample, where the smaller encoded the 
resistance (Figure 27). By subsequently testing each of the crRNAs separately, it could be 
concluded that the gene mediating the resistance belonged to the group of blaKPC. 
Similarly, a blaNDM gene was detected on one of the plasmids found in isolate DA28170. 
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Figure 27: Left: Sizes of the two plasmids found in isolate DA49173. The color of the bar indicates 
the presence (dark gray) or absence (light gray) of the resistance gene. Top Middle and Right: 
Experimental consensus barcodes of the smaller plasmid (dark gray) and larger plasmid (light gray) 
in isolate DA49173. Bottom Middle and Right: Histogram showing the location of double strand 
breaks along the contour of the small (dark gray) and large (light gray) plasmid when targeting the 
blaKPC and blaNDM gene families simultaneously. The horizontal lines in the histograms correspond 
to three standard deviations above the mean calculated value from the “balls in boxes” statistics. The 
results show that a majority of the double strand breaks occur at the same position along the sequence 
for the smaller plasmid found in the isolate, indicating the presence of a resistance gene. 
 
To summarize, with the progress presented in Paper III, the assay is capable of (i) 
detecting the size of all plasmids in a sample; (ii) providing a fingerprint which can be 
used for plasmid tracing or direct identification via a plasmid sequence database; and (iii) 
detecting the presence, or absence, of a (resistance) gene, assigning it to a precise position 
along a specific plasmid. Also, circumventing the need to manually break plasmids with 
light increases the speed of the method, as well as opens up for the possibility of future 
automatization. 
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5 Concluding Remarks and Outlook 
 
With the rates of bacteria acquiring resistance to antibiotics drastically increasing 
throughout the world, new methods allowing to rapidly detect resistant bacteria will be 
of paramount importance. Resistance mainly spreads via horizontal gene transfer of 
mobile genetic elements, such as plasmids. Therefore, the primary focus of this Thesis has 
been to develop an assay specifically targeting bacterial plasmids. 
The assay described in Paper I-III has allowed us to characterize plasmids based on size, 
their underlying DNA sequence, as well as enabled detection of resistance genes, even 
pinpointing the gene to a specific plasmid. The assay, based on optical DNA mapping, 
facilitates studies of plasmids at the single plasmid level, lowering the required amount 
of sample and allowing for investigation of structural variations. Competitive binding of 
YOYO and netropsin generates a sequence specific pattern along the DNA, which can be 
used both for tracing of plasmids, as well as for identification form a database of 
sequenced plasmids. 
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The developed assay provides a “birds-eye” view of the plasmid content in a sample and 
could either function as a complement to sequencing based strategies, or by its own for 
applications were bp resolution is not required. Compared to S1/PFGE, which provides 
information about plasmid size, the developed assay, following plasmid extraction, can 
be completed within hours instead of days.  Moreover, the assay has the ability to separate 
plasmids of the same size based on their barcode. Similar to PCR-based techniques for 
plasmid characterization, the progress in Paper III now allows the developed assay to 
target specific genes. However, in contrast to PCR-based techniques, the developed assay 
can pinpoint which particular plasmid in the sample that harbors the gene of interest. 
Moreover, if the targeted gene is not present, PCR-based methods would not reveal any 
information about the plasmid content of the sample, while the assay presented in the 
Thesis would still provide details of plasmid size and the corresponding barcode. 
Even if the developed assay in its current format provides important insights when 
studying plasmids, several key points still need to be addressed in order for the assay to 
function as a reliable tool for POC diagnostics. For the studies presented in the Thesis, all 
plasmid samples have been extracted from pre-cultivated bacteria, drastically increasing 
the lead time of the assay, thus reducing the potential impact in clinical settings. However, 
since the required amount of sample for the developed assay is very low, the need for 
cultivation could likely be significantly decreased. Refining the assay to simultaneously 
detect and characterize chromosomal fragments, would make the method more versatile, 
allowing for detection of resistance mediated by the chromosome and plasmids at the 
same time. Moreover, there would be no need for separating the plasmid DNA from the 
chromosomal DNA, simplifying the process of extracting DNA form uncultivated 
bacteria. Ways of increasing the resolution of the assay to efficiently target plasmids of 
sizes below 40 kbp, would furthermore be desirable.  
Based on the work presented in the Thesis, current efforts include (i) simplifying data 
acquisition using a custom built smartphone based fluorescence microscope, enabling the 
detection of resistance gene in remote resource limited POC settings; (ii) using the 
experimental consensus barcode as a template for assembling reads obtained from DNA 
sequencing; (iii) fabricating nanofluidic chips that permit analysis of multiple isolates in 
parallel; (iv) characterizing chromosomal and plasmid DNA simultaneously; and (v), in 
collaboration with microbiologists at Uppsala University, studying DNA from low 
concentration samples extracted directly form uncultivated bacteria. 
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Even if the resolution of the assay could potentially be improved by the use of more 
advanced optics and imaging techniques, it will never be able to compete with the bp 
resolution provided by DNA sequencing. Instead, efforts to decrease the cost, as well as 
increasing the speed and simplicity of the assay are the main focus. Moreover, there is the 
possibility to add sequence specific marks along the DNA in order to increase the 
uniqueness of the barcode. One such example is pinpointing the position of a resistance 
gene, as demonstrated in Paper III. Using Paper I as an example, the possibility to identify 
a plasmid from the database of theoretical sequences could be significantly increased by 
(i) removing all theoretical barcodes not containing the 23bp site targeted by Cas9; and 
(ii) adjusting the method of calculating the Ĉ-values, lowering the overall score for non-
matching barcodes. Hence, the size limit for a plasmid to obtain a unique match against 
the database should decrease significantly. 
In a recent paper, we describe how a filtering method enables the use of plasmid barcodes 
from only a single time frame (132), circumventing the need of averaging. Together with 
the progress made in Paper III, were plasmids no longer are linearized with light, the 
filtering methods is a key stepping stone towards turning the assay into a high 
throughput application. Moreover, single time frames, in combination with the 
competitive binding assay, has the potential to be used for mapping of large sets of DNA, 
such as the human genome. 
To conclude, the assay developed in Paper I-III provides information about the biology 
of plasmids and shows great potential as a first step of plasmid characterization. In order 
for the assay to be a reliable alternative as a POC diagnostics tool, a few key issues still 
remain to be solved. Yet, the assay in its current format provides useful insights on 
plasmids and how they spread, information which is highly desirable in the battle against 
antibiotic resistance. 
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